Section Arrow
Quote
MEDP.NASDAQ
- Medpace Holdings
Quotes are at least 15-min delayed:2024/11/16 10:03 EST
Last
 310.63
-24.21 (-7.23%)
Day High 
332.21 
Prev. Close
334.84 
1-M High
370.31 
Volume 
884.93K 
Bid
310.01
Ask
364
Day Low
310.3 
Open
332.21 
1-M Low
302.01 
Market Cap 
10.38B 
Currency USD 
P/E 31.47 
%Yield -- 
10-SMA 346.14 
20-SMA 338.87 
50-SMA 342.02 
52-W High 459.77 
52-W Low 268.795 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
10.64/13.18
Enterprise Value
10.52B
Balance Sheet
Book Value Per Share
24.63
Cash Flow
Cash Flow Yield
0.05
Income Statement
Total Revenue
1.89B
Operating Revenue Per Share
57.47
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
OPKOPKO Health1.64+0.02+1.23%-- 
DHRDanaher Corp230.5-8.88-3.71%44PE
ILMNIllumina135.05-7.19-5.05%-- 
IQVIQVIA Holdings192.68-10.26-5.06%26.6PE
TMOThermo Fisher Scientific513.08-19.94-3.74%33.07PE
Quotes are at least 15-min delayed：2024/11/16 10:03 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.